Treatment of adult MPSI mouse brains with IDUA-expressing mesenchymal stem cells decreases GAG deposition and improves exploratory behavior.

Flávia Helena da Silva, Vanessa Gonçalves Pereira, Eduardo G Yasumura, Lígia Zacchi Tenório, Leonardo Pinto de Carvalho, Bianca Cristina Garcia Lisboa, Priscila Keiko Matsumoto, Roberta Sessa Stilhano, Vivian Y Samoto, Bruno Frederico Aguilar Calegare, Letícia de Campos Brandão, Vânia D'Almeida, Thaís Rm Filippo, Marimélia Porcionatto, Leny Toma, Helena Bonciani Nader, Valderez Bastos Valero, Melissa Camassola, Nance Beyer Nardi, Sang Won Han
{"title":"Treatment of adult MPSI mouse brains with IDUA-expressing mesenchymal stem cells decreases GAG deposition and improves exploratory behavior.","authors":"Flávia Helena da Silva,&nbsp;Vanessa Gonçalves Pereira,&nbsp;Eduardo G Yasumura,&nbsp;Lígia Zacchi Tenório,&nbsp;Leonardo Pinto de Carvalho,&nbsp;Bianca Cristina Garcia Lisboa,&nbsp;Priscila Keiko Matsumoto,&nbsp;Roberta Sessa Stilhano,&nbsp;Vivian Y Samoto,&nbsp;Bruno Frederico Aguilar Calegare,&nbsp;Letícia de Campos Brandão,&nbsp;Vânia D'Almeida,&nbsp;Thaís Rm Filippo,&nbsp;Marimélia Porcionatto,&nbsp;Leny Toma,&nbsp;Helena Bonciani Nader,&nbsp;Valderez Bastos Valero,&nbsp;Melissa Camassola,&nbsp;Nance Beyer Nardi,&nbsp;Sang Won Han","doi":"10.1186/1479-0556-10-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mucopolysaccharidosis type I (MPSI) is caused by a deficiency in alpha-L iduronidase (IDUA), which leads to lysosomal accumulation of the glycosaminoglycans (GAGs) dermatan and heparan sulfate. While the currently available therapies have good systemic effects, they only minimally affect the neurodegenerative process. Based on the neuroprotective and tissue regenerative properties of mesenchymal stem cells (MSCs), we hypothesized that the administration of MSCs transduced with a murine leukemia virus (MLV) vector expressing IDUA to IDUA KO mouse brains could reduce GAG deposition in the brain and, as a result, improve neurofunctionality, as measured by exploratory activity.</p><p><strong>Methods: </strong>MSCs infected with an MLV vector encoding IDUA were injected into the left ventricle of the brain of 12- or 25-month-old IDUA KO mice. The behavior of the treated mice in the elevated plus maze and open field tests was observed for 1 to 2 months. Following these observations, the brains were removed for biochemical and histological analyses.</p><p><strong>Results: </strong>After 1 or 2 months of observation, the presence of the transgene in the brain tissue of almost all of the treated mice was confirmed using PCR, and a significant reduction in GAG deposition was observed. This reduction was directly reflected in an improvement in exploratory activity in the open field and the elevated plus maze tests. Despite these behavioral improvements and the reduction in GAG deposition, IDUA activity was undetectable in these samples. Overall, these results indicate that while the initial level of IDUA was not sustainable for a month, it was enough to reduce and maintain low GAG deposition and improve the exploratory activity for months.</p><p><strong>Conclusions: </strong>These data show that gene therapy, via the direct injection of IDUA-expressing MSCs into the brain, is an effective way to treat neurodegeneration in MPSI mice.</p>","PeriodicalId":12596,"journal":{"name":"Genetic Vaccines and Therapy","volume":" ","pages":"2"},"PeriodicalIF":0.0000,"publicationDate":"2012-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1479-0556-10-2","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genetic Vaccines and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1479-0556-10-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Background: Mucopolysaccharidosis type I (MPSI) is caused by a deficiency in alpha-L iduronidase (IDUA), which leads to lysosomal accumulation of the glycosaminoglycans (GAGs) dermatan and heparan sulfate. While the currently available therapies have good systemic effects, they only minimally affect the neurodegenerative process. Based on the neuroprotective and tissue regenerative properties of mesenchymal stem cells (MSCs), we hypothesized that the administration of MSCs transduced with a murine leukemia virus (MLV) vector expressing IDUA to IDUA KO mouse brains could reduce GAG deposition in the brain and, as a result, improve neurofunctionality, as measured by exploratory activity.

Methods: MSCs infected with an MLV vector encoding IDUA were injected into the left ventricle of the brain of 12- or 25-month-old IDUA KO mice. The behavior of the treated mice in the elevated plus maze and open field tests was observed for 1 to 2 months. Following these observations, the brains were removed for biochemical and histological analyses.

Results: After 1 or 2 months of observation, the presence of the transgene in the brain tissue of almost all of the treated mice was confirmed using PCR, and a significant reduction in GAG deposition was observed. This reduction was directly reflected in an improvement in exploratory activity in the open field and the elevated plus maze tests. Despite these behavioral improvements and the reduction in GAG deposition, IDUA activity was undetectable in these samples. Overall, these results indicate that while the initial level of IDUA was not sustainable for a month, it was enough to reduce and maintain low GAG deposition and improve the exploratory activity for months.

Conclusions: These data show that gene therapy, via the direct injection of IDUA-expressing MSCs into the brain, is an effective way to treat neurodegeneration in MPSI mice.

Abstract Image

Abstract Image

Abstract Image

用表达idua的间充质干细胞治疗成年MPSI小鼠脑可减少GAG沉积并改善探索行为。
背景:I型粘多糖病(MPSI)是由α - l糖醛酸酶(IDUA)缺乏引起的,它导致溶酶体积聚糖胺聚糖(GAGs)皮肤聚糖和硫酸肝素。虽然目前可用的治疗方法具有良好的全身效果,但它们对神经退行性过程的影响很小。基于间充质干细胞(MSCs)的神经保护和组织再生特性,我们假设用表达IDUA的小鼠白血病病毒(MLV)载体转导的MSCs进入IDUA KO小鼠大脑可以减少大脑中的GAG沉积,从而改善神经功能。方法:将编码IDUA的MLV载体感染的MSCs注射到12或25月龄的IDUA KO小鼠的左心室。观察实验组小鼠在高架+迷宫和开阔场地试验中的行为,为期1 ~ 2个月。在这些观察之后,大脑被移除进行生化和组织学分析。结果:经过1 ~ 2个月的观察,几乎所有处理小鼠的脑组织中都有转基因基因的存在,并且观察到GAG沉积明显减少。这种减少直接反映在开阔场地的探索活动的改善和高强度的迷宫测试中。尽管这些行为改善和GAG沉积减少,但在这些样本中未检测到IDUA活性。总的来说,这些结果表明,虽然初始水平的IDUA不能持续一个月,但它足以减少和维持低GAG沉积,并在几个月内提高勘探活动。结论:通过向脑内直接注射表达idua的MSCs进行基因治疗是治疗MPSI小鼠神经退行性变的有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信